Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2016-03-25 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
第七届董事会第六次会议独立董事关于继续聘用会计师事务所事项的事前认可意见
Audit Report / Information Classification · 90% confidence The document is a statement from independent directors providing a prior approval opinion on the proposal to continue hiring an accounting firm for the 2016 annual financial audit. It discusses the audit firm's past performance and recommends reappointment. The document is short (393 characters) and does not contain actual financial statements or detailed audit results. It is an announcement related to audit services rather than a full audit report or annual report. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or certification. FY 2016
2016-03-25 Chinese
第七届监事会第五次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 紫光古汉集团股份有限公司 regarding the approval of the 2015 annual report, financial statements, profit distribution plan, internal control evaluation report, and other related matters. It includes voting results and confirms the legality and accuracy of the reports but does not contain the full annual report or detailed financial statements itself. The document is relatively short (1560 characters) and serves as an official announcement of meeting resolutions and approvals rather than the full report. Therefore, it fits best under Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the voting outcomes on key annual report items and related proposals that will be submitted to the shareholders' meeting.
2016-03-25 Chinese
2015年年度报告（已取消）
Annual Report Classification · 100% confidence The document is titled "紫光古汉集团股份有限公司 2015 年年度报告全文" which translates to "Unisplendour Guhan Group Corporation Limited 2015 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, business summary, financial statements, and governance information. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes comprehensive financial figures, management commentary, and detailed disclosures consistent with an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2015
2016-03-25 Chinese
2015年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2015 年年度报告摘要" which translates to "2015 Annual Report Summary". It contains detailed financial data for the year 2015, including revenue, net profit, earnings per share, and asset information. It also discusses management's analysis of the financial results, business operations, and changes in accounting policies. The document is comprehensive and covers the company's yearly performance, which aligns with the definition of an Annual Report (10-K). The length of the document (5796 characters) and the detailed financial and operational data confirm it is the report itself, not just an announcement or summary notice. Therefore, the correct classification is Annual Report (10-K). FY 2015
2016-03-25 Chinese
第七届董事会第六次会议独立董事意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion report related to the company's 2015 annual matters, including opinions on related party transactions, inventory write-offs, internal control evaluation report, profit distribution plan, and board director election. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and discusses governance and audit-related matters. The document is not a full annual report or audit report but rather a formal opinion statement by independent directors on specific governance and financial issues. It is not a meeting presentation, call transcript, or voting result announcement. The content aligns best with Board/Management Information (MANG) as it includes opinions on board matters and governance issues, including director nomination. The document length is short (1590 characters), and it contains substantive content rather than just an announcement or certification, so it is not RNS or RPA. Therefore, the classification is MANG with high confidence.
2016-03-25 Chinese
2015年度独立董事述职报告（王涌）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for the year 2015" from 紫光古汉集团股份有限公司. It details the independent director's attendance at board meetings, opinions on various company matters including internal control reports, audit firm appointment, amendments to company articles, and opinions on non-public stock issuance and related party transactions. The content focuses on the independent director's duties, opinions, and oversight activities during the year 2015. It is a detailed report on board/management oversight and governance-related activities rather than a full annual report or audit report. It is not a simple announcement or certification but a substantive report on management and board activities. Therefore, the document fits best under Board/Management Information (MANG).
2016-03-25 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.